Lv11
20 积分 2023-10-17 加入
Clinical Outcomes of Perioperative Immunotherapy in Resectable Non–Small Cell Lung Cancer
8小时前
待确认
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
1个月前
已完结
Multi-omics models for predicting prognosis in non-small cell lung cancer patients following chemotherapy and radiotherapy: A multi-center study
2个月前
已完结
Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
2个月前
已关闭
Spatial biology captures the effects of neoadjuvant chemo-immunotherapy in lung cancer
2个月前
已完结
Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trials
2个月前
已完结
Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
2个月前
已关闭
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysis
2个月前
已完结
Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?
2个月前
已关闭
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
3个月前
已完结
皖公网安备34019202002308
